Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities

Philamer C Calses1, James J Crawford2, Jennie R Lill3

  • 1Department of Discovery Oncology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA; Department of Microchemistry, Proteomics, and Lipidomics, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.

Trends in Cancer
|June 9, 2019
PubMed

Insights

The Hippo pathway regulates development and its dysregulation drives cancer. This review covers Hippo pathway's role in cancer genetics, therapy resistance, and immunogenicity, summarizing therapeutic targeting efforts.

Area of Science:

  • Oncology
  • Molecular Biology
  • Developmental Biology

Background:

  • The Hippo pathway is crucial for organ size control and development.
  • Its dysregulation is implicated in numerous human cancers.
  • Targeting the Hippo pathway is a key strategy for cancer intervention.

Purpose of the Study:

  • To review recent advances in understanding the Hippo pathway in cancer.
  • To discuss genetic aberrations affecting Hippo pathway components in tumorigenesis.
  • To explore the Hippo pathway's role in cancer therapy resistance and immunogenicity.

Main Methods:

  • Literature review of recent research on the Hippo pathway and cancer.
  • Analysis of genetic alterations (amplification, deletion, fusion) in Hippo pathway genes.
  • Examination of studies on Hippo pathway's influence on therapeutic response and anti-tumor immunity.

Main Results:

  • Genetic aberrations in core Hippo pathway factors are mechanisms of cancer development.
  • The Hippo pathway influences resistance to cancer therapies.
  • Hippo pathway activity impacts tumor immunogenicity.

Conclusions:

  • The Hippo pathway is a significant factor in cancer biology, affecting development and progression.
  • Understanding its genetic underpinnings and roles in therapy resistance and immunity is vital.
  • Targeting the Hippo pathway holds promise for novel cancer treatments.

Related Concept Videos

GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.8K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
48.9K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.1K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K